About This Source - Bloomberg QuickTake: Now
Bloomberg L.P. is a privately held financial, software, data, and media company headquartered in Midtown Manhattan, New York City.
It was founded by Michael Bloomberg in 1981, with the help of Thomas Secunda, Duncan MacMillan, Charles Zegar, and a 12% ownership investment by Merrill Lynch.
Recent from Bloomberg QuickTake: Now:
Bloomberg Quicktake: Now published this video item, entitled “Biden Orders Increase in Weekly Vaccine Shipment to States to 10 Million Doses” – below is their description.
The Biden administration said it intends to order 100 million more doses each of Pfizer Inc. and Moderna Inc.’s coronavirus vaccines, and at least temporarily speed up shipments to states to about 10 million doses a week.
The new purchases would increase total U.S. orders for the two approved vaccines by 50%, to about 600 million shots, according to a senior administration official. Delivering 10 million doses to states would represent about a 16% increase from the current weekly pace, though the higher pace may only last three weeks.
President Joe Biden has pledged to administer 100 million shots in his first 100 days in office, though it wasn’t immediately clear if the measures announced Tuesday would help him more easily meet that goal. The effort is also constrained by limits on the number of sites and medical professionals who can give shots. The official said the administration is working with states to relieve that bottleneck, including by delivering more doses through retail pharmacies.
The official briefed reporters Tuesday on condition of anonymity ahead of an update on the pandemic from Biden.
The president has made curbing the pandemic his top priority, while warning it will drag on for months even with more aggressive action by the government. He has pleaded with Congress to pass his proposed $1.9 trillion pandemic relief bill, which would include billions of dollars to accelerate vaccinations.
Biden administration officials briefed governors on the vaccination effort on Tuesday, as well.
Biden said Monday that he thinks the U.S. can reach 1.5 million vaccinations per day, and that any American who wants a shot may be able to get one by spring. His deputies have tamped down expectations following that remark, returning to previous projections that most U.S. adults won’t be vaccinated until later in the year.
“Everybody won’t be eligible this spring, as you all know, even as the CDC continues to provide updated guidance,” White House Press Secretary Jen Psaki said Tuesday.
The U.S. is administering about 1.3 million doses per day right now, according to an average compiled by the Bloomberg Vaccine Tracker. That includes Monday, when only 1.1 million shots were recorded.
The transition between administrations created confusion about how many shots, if any, the federal government had received but not yet allocated or shipped to states. Shortly before he left office, former President Donald Trump’s administration announced it would release second doses of the Pfizer and Moderna shots that had been withheld. States subsequently complained that they saw no spike in shipments.
The senior administration official who briefed reporters on Tuesday said the federal government does not have a significant inventory of shots on hand, beyond what the official described as a small reserve for emergencies.
The two vaccines approved so far, from Pfizer and Moderna, each require two doses — meaning that 100 million shots would inoculate half as many people. Approval of a third candidate would speed vaccination rates.
Johnson & Johnson is expected to soon report results of clinical trials of its coronavirus vaccine, which requires only one shot, and could receive FDA authorization soon afterward. But the official said the Biden administration is not counting on having any additional authorized vaccines before the summer.
The U.S. recorded 166,000 new coronavirus cases on Monday, down from record highs earlier this month but still well above figures seen throughout the fall. Another 1,757 people died in the U.S., pushing the pandemic’s toll to over 422,000 dead.Bloomberg Quicktake: Now YouTube Channel
Got a comment? Leave your thoughts in the comments section, below. Please note comments are moderated before publication.
In This Story: COVID-19
Covid-19 is the official WHO name given to the novel coronavirus which broke out in late 2019 and began to spread in the early months of 2020.
Symptoms of coronavirus
The main symptoms of coronavirus are:
- a persistent new cough (non productive, dry)
- a high temperature (e.g. head feels warm to the touch)
- shortness of breath (if this is abnormal for the individual, or increased)
Latest News about Covid-19
Below are stories from around the globe related to the 2020 outbreak of novel Coronavirus – since the WHO gave the Covid-19 naming. Most recent items are posted nearest the top.
5 Recent Items: COVID-19
In This Story: Joe Biden
Joe Biden is an American politician serving as the 46th and current president of the United States. A member of the Democratic Party, he served as the 47th vice president from 2009 to 2017 under Barack Obama and represented Delaware in the United States Senate from 1973 to 2009.
He is married to Dr Jill Biden.
Books by Joe Biden #Ad
6 Recent Items: Joe Biden
In This Story: Moderna
Moderna is an American biotechnology company based in Cambridge, Massachusetts that focuses on drug discovery, drug development, and vaccine technologies based exclusively on messenger RNA.
CEO: Stéphane Bancel (2011–)
Stock ticker: (NASDAQ:MRNA)
5 Recent Items: Moderna
In This Story: Pfizer
Pfizer Inc. (NYSE: PFE) is an American multinational pharmaceutical corporation headquartered in New York City. In 2012, it was one of the world’s largest pharmaceutical companies and ranked 57 on the 2018 Fortune 500 list of the largest United States corporations by total revenue.
5 Recent Items: Pfizer
In This Story: Vaccine
A vaccine is a biological preparation that provides active acquired immunity to a particular infectious disease. A vaccine typically contains an agent that resembles a disease-causing microorganism and is often made from weakened or killed forms of the microbe, its toxins, or one of its surface proteins.